{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:03:06Z","timestamp":1784779386409,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006702","name":"Universidade Do Estado Do Rio De Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic steatotic liver disease (MASLD) lacks effective pharmacological therapies targeting mitochondrial dysfunction, a central driver of disease progression. We hypothesized that dapagliflozin attenuates MASLD progression by promoting an indirect systemic fasting-mimicking state, thereby proposing the hypothesis of mitochondrial restoring mitochondrial bioenergetics restoration via modulation of the SIRT1\u2013PGC-1\u03b1 signaling pathway. C57BL\/6 mice were fed either a control diet or a high-fat diet, associated, respectively, with drinking water or water with 15% fructose. From the 10th to the 16th week, the animals received, by orogastric gavage, saline solution or dapagliflozin (10 mg\/kg). Biochemical analyses, magnetic resonance imaging, oral glucose tolerance tests, stereology, and ultrastructural analysis of the liver, as well as Western blotting using mitochondrial markers, were performed. The study showed that exposure to the high-fat diet associated with fructose effectively mimicked the main aspects of obesity and MASLD. Intervention resulted in a reduction in adiposity without compromising muscle mass, preservation of mitochondrial integrity, improvement in mitochondrial bioenergetics, and attenuation of steatosis and hepatic cellular stress. These results suggest an association with the NT-PGC-1\u03b1\u2013NRF1 axis; our study hypothesizes that this acts as a compensatory mechanism. These findings support further investigation of dapagliflozin as a potential therapeutic strategy for MASLD.<\/jats:p>","DOI":"10.1007\/s00210-026-05723-w","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:41:58Z","timestamp":1784778118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dapagliflozin attenuates hepatic steatosis and induces a fasting-mimicking metabolic state in C57BL\/6 mice"],"prefix":"10.1007","author":[{"given":"Pericles Fabr\u00edcio","family":"Gomes-Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina da Silva","family":"Valentim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherley Borba Vieira","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica Aiceles de Medeiros","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00edssa Leal de Carvalho dos Santos","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Rogerio Silva","family":"de Paiva-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Roosevelt da Concei\u00e7\u00e3o Souz","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Lucas do C\u00e9u","family":"Amparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isalira Peroba","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Lontro","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluana Santana","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Gomes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia Medeiros","family":"Nehme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Cristina","family":"Lisboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samara Cristina","family":"Ferreira-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00edssila","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Jos\u00e9","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemima Fuentes Ribeiro","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"2","key":"5723_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/dom.12189","volume":"16","author":"J Bolinder","year":"2014","unstructured":"Bolinder J et al (2014) Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obes Metab 16(2):159\u2013169. https:\/\/doi.org\/10.1111\/dom.12189","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"5723_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.dsx.2019.01.031","volume":"13","author":"M Calapkulu","year":"2019","unstructured":"Calapkulu M et al (2019) Lipid profile in type 2 diabetic patients with new dapagliflozin treatment: clinical experience from a six-month retrospective study. Diabetes Metab Syndr 13(2):1031\u20131034. https:\/\/doi.org\/10.1016\/j.dsx.2019.01.031","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"5723_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","volume":"11","author":"C Canto","year":"2010","unstructured":"Canto C et al (2010) Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11(3):213\u2013219. https:\/\/doi.org\/10.1016\/j.cmet.2010.02.006","journal-title":"Cell Metab"},{"key":"5723_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101071","volume":"42","author":"H Chae","year":"2020","unstructured":"Chae H et al (2020) SGLT2 is not expressed in pancreatic \u03b1- and \u03b2-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans. Mol Metab 42:101071. https:\/\/doi.org\/10.1016\/j.molmet.2020.101071","journal-title":"Mol Metab"},{"issue":"23","key":"5723_CR5","doi-asserted-by":"publisher","first-page":"18039","DOI":"10.1074\/jbc.M109.077651","volume":"285","author":"JS Chang","year":"2010","unstructured":"Chang JS et al (2010) Regulation of NT-PGC-1alpha subcellular localization and function by protein kinase A-dependent modulation of nuclear export by CRM1. J Biol Chem 285(23):18039\u201318050. https:\/\/doi.org\/10.1074\/jbc.M109.077651","journal-title":"J Biol Chem"},{"issue":"1","key":"5723_CR6","doi-asserted-by":"publisher","first-page":"7876","DOI":"10.1038\/s41598-018-26268-2","volume":"8","author":"JS Chang","year":"2018","unstructured":"Chang JS et al (2018) A map of the PGC-1alpha- and NT-PGC-1alpha-regulated transcriptional network in brown adipose tissue. Sci Rep 8(1):7876. https:\/\/doi.org\/10.1038\/s41598-018-26268-2","journal-title":"Sci Rep"},{"key":"5723_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110185","volume":"142","author":"ACN de Moraes","year":"2021","unstructured":"de Moraes ACN et al (2021) Resveratrol promotes liver regeneration in drug-induced liver disease in mice. Food Res Int 142:110185. https:\/\/doi.org\/10.1016\/j.foodres.2021.110185","journal-title":"Food Res Int"},{"issue":"8","key":"5723_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/oby.2012.59","volume":"20","author":"JJ Devenny","year":"2012","unstructured":"Devenny JJ et al (2012) Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. Obesity Silver Spring 20(8):1645\u20131652. https:\/\/doi.org\/10.1038\/oby.2012.59","journal-title":"Obesity Silver Spring"},{"issue":"7","key":"5723_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cells12070976","volume":"12","author":"ML Dias","year":"2023","unstructured":"Dias ML et al (2023) Cirrhotic liver sustains in situ regeneration of acellular liver scaffolds after transplantation into G-CSF-treated animals. Cells Basel 12(7):976. https:\/\/doi.org\/10.3390\/cells12070976","journal-title":"Cells Basel"},{"issue":"8","key":"5723_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2020.151646","volume":"122","author":"H Duranova","year":"2020","unstructured":"Duranova H et al (2020) Mitochondria: a worthwhile object for ultrastructural qualitative characterization and quantification of cells at physiological and pathophysiological states using conventional transmission electron microscopy. Acta Histochem 122(8):151646. https:\/\/doi.org\/10.1016\/j.acthis.2020.151646","journal-title":"Acta Histochem"},{"issue":"4","key":"5723_CR11","doi-asserted-by":"publisher","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos PJ, Auwerx J (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93(4):884S-890S. https:\/\/doi.org\/10.3945\/ajcn.110.001917","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"5723_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1172\/JCI72227","volume":"124","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E et al (2014) Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest 124(2):499\u2013508. https:\/\/doi.org\/10.1172\/JCI72227","journal-title":"J Clin Invest"},{"issue":"9","key":"5723_CR13","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/db16-0058","volume":"65","author":"SA Hawley","year":"2016","unstructured":"Hawley SA et al (2016) The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels. Diabetes 65(9):2784\u20132794. https:\/\/doi.org\/10.2337\/db16-0058","journal-title":"Diabetes"},{"issue":"7","key":"5723_CR14","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1002\/tox.24275","volume":"39","author":"CF Jhuo","year":"2024","unstructured":"Jhuo CF et al (2024) Teaghrelin protects dopaminergic neurons in an MPTP-induced Parkinson\u2019s disease model by promoting PINK1\/Parkin-mediated mitophagy and AMPK\/SIRT1\/PGC-1alpha-mediated mitochondrial biogenesis. Environ Toxicol 39(7):4022\u20134034. https:\/\/doi.org\/10.1002\/tox.24275","journal-title":"Environ Toxicol"},{"issue":"7121","key":"5723_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840\u2013846. https:\/\/doi.org\/10.1038\/nature05482","journal-title":"Nature"},{"issue":"7","key":"5723_CR16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.89091","volume":"17","author":"S Khanna","year":"2025","unstructured":"Khanna S, Malik M, Ahmad R (2025) Effects of dapagliflozin vs vildagliptin on the lipid profile of patients with uncontrolled type 2 diabetes. Cureus 17(7):e89091. https:\/\/doi.org\/10.7759\/cureus.89091","journal-title":"Cureus"},{"issue":"5","key":"5723_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C et al (2015) Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 21(5):739\u2013746. https:\/\/doi.org\/10.1016\/j.cmet.2015.04.004","journal-title":"Cell Metab"},{"issue":"3","key":"5723_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1538\/expanim.19-0098","volume":"69","author":"J Li","year":"2020","unstructured":"Li J et al (2020) High fat diet induced obesity model using four strains of mice: Kunming, C57BL\/6. Balb\/c ICR Exp Anim 69(3):326\u2013335. https:\/\/doi.org\/10.1538\/expanim.19-0098","journal-title":"Balb\/c ICR Exp Anim"},{"issue":"1","key":"5723_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02045-0","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y et al (2024) Updated mechanisms of MASLD pathogenesis. Lipids Health Dis 23(1):117. https:\/\/doi.org\/10.1186\/s12944-024-02045-0","journal-title":"Lipids Health Dis"},{"issue":"4","key":"5723_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00467-020-04669-2","volume":"36","author":"M Litwin","year":"2021","unstructured":"Litwin M, Kulaga Z (2021) Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol 36(4):825\u2013837. https:\/\/doi.org\/10.1007\/s00467-020-04669-2","journal-title":"Pediatr Nephrol"},{"key":"5723_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-016-0072-7","volume":"13","author":"I Lozano","year":"2016","unstructured":"Lozano I et al (2016) High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond) 13:15. https:\/\/doi.org\/10.1186\/s12986-016-0072-7","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"5723_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1590\/S0001-37652003000400006","volume":"75","author":"CA Mandarim-de-Lacerda","year":"2003","unstructured":"Mandarim-de-Lacerda CA (2003) Stereological tools in biomedical research. An Acad Bras Cienc 75(4):469\u2013486. https:\/\/doi.org\/10.1590\/S0001-37652003000400006","journal-title":"An Acad Bras Cienc"},{"key":"5723_CR23","doi-asserted-by":"publisher","unstructured":"Mandarim-de-Lacerda CA, Del Sol M (2017) Tips for studies with quantitative morphology (morphometry and stereology). Int J Morphol 35(4). https:\/\/doi.org\/10.4067\/S0717-95022017000401482","DOI":"10.4067\/S0717-95022017000401482"},{"issue":"1","key":"5723_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbr.2006.12.011","volume":"178","author":"C Messier","year":"2007","unstructured":"Messier C et al (2007) The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL\/6 mice. Behav Brain Res 178(1):139\u2013145. https:\/\/doi.org\/10.1016\/j.bbr.2006.12.011","journal-title":"Behav Brain Res"},{"key":"5723_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200479","author":"JGO Neto","year":"2023","unstructured":"Neto JGO et al (2023) Effect of gestational fish oil supplementation on liver metabolism and mitochondria of male and female rat offspring programmed by maternal high\u2010fat diet. Mol Nutr Food Res. https:\/\/doi.org\/10.1002\/mnfr.202200479","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"5723_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","volume":"13","author":"M Packer","year":"2020","unstructured":"Packer M (2020) Cardioprotective effects of sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 inhibitors. Circ Heart Fail 13(9):e007197. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007197","journal-title":"Circ Heart Fail"},{"issue":"3","key":"5723_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dci19-0074","volume":"43","author":"M Packer","year":"2020","unstructured":"Packer M (2020) SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action. Diabetes Care 43(3):508\u2013511. https:\/\/doi.org\/10.2337\/dci19-0074","journal-title":"Diabetes Care"},{"key":"5723_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.725084","author":"IPR Ramos","year":"2021","unstructured":"Ramos IPR et al (2021) Granulocyte colony-stimulating factor treatment before radiotherapy protects against radiation-induced liver disease in mice. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.725084","journal-title":"Front Pharmacol"},{"issue":"7029","key":"5723_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT et al (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113\u2013118. https:\/\/doi.org\/10.1038\/nature03354","journal-title":"Nature"},{"issue":"5\u20136","key":"5723_CR30","first-page":"374","volume":"60","author":"M Rorive","year":"2005","unstructured":"Rorive M et al (2005) Obesity and type 2 diabetes. Rev Med Liege 60(5\u20136):374\u2013382","journal-title":"Rev Med Liege"},{"issue":"1","key":"5723_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126(1):12\u201322. https:\/\/doi.org\/10.1172\/JCI77812","journal-title":"J Clin Invest"},{"issue":"1","key":"5723_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jdi.12889","volume":"10","author":"T Sasaki","year":"2019","unstructured":"Sasaki T, Sugawara M, Fukuda M (2019) Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and metabolic profile: 52-week LIGHT study. J Diabetes Investig 10(1):108\u2013117. https:\/\/doi.org\/10.1111\/jdi.12889","journal-title":"J Diabetes Investig"},{"issue":"7","key":"5723_CR33","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","volume":"1813","author":"RC Scarpulla","year":"2011","unstructured":"Scarpulla RC (2011) Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813(7):1269\u20131278. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.09.019","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"5723_CR34","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","volume":"61","author":"S Softic","year":"2016","unstructured":"Softic S, Cohen DE, Kahn CR (2016) Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci 61(5):1282\u20131293. https:\/\/doi.org\/10.1007\/s10620-016-4054-0","journal-title":"Dig Dis Sci"},{"key":"5723_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100514","author":"AFP Souza","year":"2022","unstructured":"Souza AFP et al (2022) Maternal isocaloric high\u2010fat diet induces liver mitochondria maladaptations and homeostatic disturbances intensifying mitochondria damage in response to fructose intake in adult male rat offspring. Mol Nutr Food Res. https:\/\/doi.org\/10.1002\/mnfr.202100514","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"5723_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tem.2016.12.006","volume":"28","author":"NE Sunny","year":"2017","unstructured":"Sunny NE, Bril F, Cusi K (2017) Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies. Trends Endocrinol Metab 28(4):250\u2013260. https:\/\/doi.org\/10.1016\/j.tem.2016.12.006","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"5723_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-07713-9","volume":"8","author":"NK Talari","year":"2025","unstructured":"Talari NK et al (2025) Functional compartmentalization of hepatic mitochondrial subpopulations during MASH progression. Commun Biol 8(1):258. https:\/\/doi.org\/10.1038\/s42003-025-07713-9","journal-title":"Commun Biol"},{"key":"5723_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114997","volume":"396","author":"L Thongnak","year":"2020","unstructured":"Thongnak L et al (2020) Effects of dapagliflozin and statins attenuate renal injury and liver steatosis in high-fat\/high-fructose diet-induced insulin-resistant rats. Toxicol Appl Pharmacol 396:114997. https:\/\/doi.org\/10.1016\/j.taap.2020.114997","journal-title":"Toxicol Appl Pharmacol"},{"key":"5723_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-med-051013-110046","volume":"66","author":"V Vallon","year":"2015","unstructured":"Vallon V (2015) The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med 66:255\u2013270. https:\/\/doi.org\/10.1146\/annurev-med-051013-110046","journal-title":"Annu Rev Med"},{"issue":"6","key":"5723_CR40","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K et al (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45(6):1366\u20131374. https:\/\/doi.org\/10.1002\/hep.21655","journal-title":"Hepatology"},{"issue":"47","key":"5723_CR41","doi-asserted-by":"publisher","first-page":"32813","DOI":"10.1074\/jbc.M109.047373","volume":"284","author":"Y Zhang","year":"2009","unstructured":"Zhang Y et al (2009) Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J Biol Chem 284(47):32813\u201332826. https:\/\/doi.org\/10.1074\/jbc.M109.047373","journal-title":"J Biol Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05723-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05723-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05723-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:42:00Z","timestamp":1784778120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05723-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":41,"alternative-id":["5723"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05723-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal handling and experimentation protocol was approved by the animal experimentation ethics committee of the State University of Rio de Janeiro (04\/12\/2024).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}